Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hemostemix V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc is a clinical-stage biotechnology company. The company's principal business activity is to develop, manufacture, and commercialize blood-derived cell therapies for medical conditions. Its technology platform for developing autologous cell therapies is for the treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:HEM)

Fundamentals Snapshot (TSXV:HEM)

Current News (TSXV:HEM)

Hemostemix Announces Unit Private Placement

Newsfile 2 days ago

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire May 3, 2023

IIROC Trading Resumption - HEM

Canada NewsWire May 2, 2023

Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company

Newsfile May 2, 2023

IIROC Trading Halt - HEM

Canada NewsWire May 2, 2023

Hemostemix' Second Round Interviews with Executive Vice President Business Development Candidates

Newsfile April 3, 2023

Hemostemix Engages Montreal's RobboDesign to SEO Its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally

Newsfile March 29, 2023

Hemostemix Closes $762,400 of The Unit Private Placement

Newsfile March 21, 2023

Hemostemix Unit Offering Repriced

Newsfile March 8, 2023
View More News ››

Opinion & Analysis (TSXV:HEM)

Shaping the Future of Regenerative Medicine Today

Dave Jackson February 11, 2021

Hemostemix Founder: A Man with a Compassionate Heart

Featured Submission December 15, 2020

Shaping the Future of Medicine by Delivering Regenerative Medicines

Dave Jackson December 9, 2020
View More Opinion ››

Bullboard Posts (TSXV:HEM)

NCP

Great news for NCP...not so good for the sp...not even a blip!!!! What ever happened to the Canadian researcher that they collaborated...
ENEMENEMYNEMO - May 2, 2023

Force Family Office webinar

<< View Post To Watch Video >>
PowerOfTheSun - April 6, 2023

Hmmm

That's an interesting PR.  Gotta give it to Smeenk, he certainly works for his money...in weird ways! Podiatry is actually a...
ENEMENEMYNEMO - April 3, 2023

RE:HEM has piqued the interest of industry participants.

Nice to meet you, bot #4444!
JocetooBad - March 22, 2023

HEM has piqued the interest of industry participants.

HEM has garnered good investor attention in the industry with its re-pricing tactic on its unit offering. The shares jumped with a nice...
khandaanita4444 - March 20, 2023

Offers

The warrants need a wayyyyy lower price. Looking at other similar pp it should be like 30c The 30k thing is really weird I hope to hell...
ENEMENEMYNEMO - March 9, 2023
View more Bullboard ››

NetraMark Holdings Inc.

NetraMark Holdings Inc.

NetraMark is a company focused on being a leader in the development of Artificial Intelligence (AI) / Machine Learning (ML ...
View More »